期刊文献+

胸中段食管癌根治性放射治疗sIMRT与TOMO靶区及危及器官剂量学比较 被引量:1

Comparison of the sIMRT and TOMO target areas and dosimetry of organs at risk in radical radiotherapy for middle thoracic esophageal cancer
暂未订购
导出
摘要 目的探讨胸中段食管癌根治性放疗静态调强(sIMRT)和螺旋断层调强(TOMO)两种技术靶区和危及器官的剂量学参数,为临床治疗选择提供参考。方法选取2015年9月至2019年9月本院收治的17例胸中段食管癌患者作为研究对象,均设计sIMRT计划和TOMO计划,分析比较两组计划靶区和危及器官的剂量学参数。结果靶区PGTV和PTV TOMO的D2、HI均明显低于sIMRT,CI明显高于sIMRT(P<0.05);靶区PTV TOMO的D98高于sIMRT(P<0.05)。双肺的低剂量区V5、V10比较,sIMRT低于TOMO(P<0.05);高剂量区V20、V30比较,sIMRT高于TOMO(P<0.05)。心脏高剂量区V20、V25、V30、V40比较,sIMRT均高于TOMO(P<0.05)。脊髓的D2比较,sIMRT显著高于TOMO,差异具有统计学意义(P<0.05)。结论胸中段食管癌根治性放疗sIMRT、TOMO计划均能满足临床治疗要求,但TOMO靶区的适形性和均匀性明显优于sIMRT,在危及器官的保护上,sIMRT双肺及心脏低剂量区V5、V10的保护优于TOMO,但TOMO在高剂量区V20、V30的保护优于sIMRT。两种不同的放疗技术各有其优劣,临床可以根据实际情况和侧重点,选择适合患者自身的放疗技术。 Objective To explore the technology target area and dosimetric parameters of organs at risk of static intensity-modulated radiotherapy(sIMRT) and tomotherapy(TOMO) in radical radiotherapy for middle thoracic esophageal cancer, to provide reference for clinical treatment selection. Methods Sventeen patients with middle thoracic esophageal cancer admitted in our hospital from September 2015 to September 2019 were selected as the study objects. For each patient, both sIMRT and TOMO plans were designed. The target areas and dosimetric parameters of organs at risk of the two plans were analyzed and compared. Results In the target area PGTV and PTV, D2 and HI of TOMO were significantly lower than those of sIMRT, and CI was significantly higher than that of sIMRT(P<0.05);in the target area PTV, the D98 of TOMO was higher than that of sIMRT(P<0.05). In the low dose area of all-lungs, V5 and V10 of sIMRT were lower than those of TOMO(P<0.05);while in the high dose area, V20 and V30 of sIMRT were higher than those of TOMO(P<0.05). In the high dose area of heart, the V20, V25, V30 and V40 of sIMRT were higher than those of TOMO, the differences were statistically significant(P<0.05). The D2 of spinal cord of sIMRT was significantly higher than that of TOMO(P<0.05).Conclusion Both sIMRT and TOMO plans of radical radiotherapy for middle thoracic esophageal cancer can meet the requirements of clinical treatment, but the conformability and uniformity of the target area of TOMO are significantly better than those of sIMRT. On the protection of organs at risk, the V5 and V10 in the low dose area of all-lungs and heart of the sIMRT are better than those of TOMO, but V20 and V30 in the high dose area of the TOMO are better than those of sIMRT.The two different radiotherapy technologies have their own advantages and disadvantages, so they can be used clinically according to the actual situation and focus to choose the appropriate radiotherapy technology for patients.
作者 赵彪 袁美芳 潘香 杨毅 马立双 孙朝细 ZHAO Biao;YUAN Mei-fang;PAN Xiang;YANG Yi;MA Li-shuang;SUN Chao-xi(Radiotherapy Department,Yunnan Cancer Hospital/the Third Affiliated Hospital of Kunming Medical University,Kunming 650118,China;Neurosurgery Department,Yunnan Cancer Hospital/the Third Affiliated Hospital of Kunming Medical University,Kunming 650118,China)
出处 《临床医学研究与实践》 2019年第36期39-41,共3页 Clinical Research and Practice
关键词 食管癌 静态调强放疗 螺旋断层调强放疗 剂量学 胸中段食管癌 根治性放射 esophageal cancer static intensity -modulated radiotherapy tomotherapy dosimetry middle thoracic esophageal cancer radical radiotherapy
  • 相关文献

参考文献4

二级参考文献68

  • 1JIAO Yang1,QIU ZhiFeng1,XIE Jing1,LI DongJing2 & LI TaiSheng1 1 Department of Infectious Disease,Peking Union Medical College Hospital,Peking Union Medical College & Chinese Academy of Medical Sciences,Beijing,China,2 Department of Special Care Unit,Peking Union Medical College Hospital,Peking Union Medical College & Chinese Academy of Medical Sciences,Beijing,China.Reference ranges and age-related changes of peripheral blood lymphocyte subsets in Chinese healthy adults[J].Science China(Life Sciences),2009,52(7):643-650. 被引量:21
  • 2Clarke M,Collins R,Darby S,Davies C,Elphinstone P,Evans E,Godwin J,Gray R,Hicks C,James S,MacKinnon E,McGale P,McHugh T,Peto R,Taylor C,Wang Y.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. The Lancet . 2005
  • 3Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiatio- n therapy for the treatment of intraductal breast cancer:, finding from National Surgical Adjuvant Breast and Bowel Project B-17 [J]. J Clin Oncol, 1998, 16(2): 441-452.
  • 4lulien JP, Bijker N, Fentiman IS, et all. Radiotherapy in breast-e- onserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase IH trial 10 853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group[J]. Lancet, 2000, 355(9203): 528-533.
  • 5Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow- up of a randomized trial comparing radical mastectomy, total m- astectomy, and total mastectomy followed by irradiation[J]. N E- ngl J Med, 2002, 347(8): 567-575.
  • 6Veronesi U, Cascinelli N, Mariani I, et al. Twenty-year follow- ap of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J M- ed, 2002, 347(16): 1227-1232.
  • 7Rusthoven KE, Carter DL, Howell K, et al. Accelerated partial- breast intensity-modulated radiotherapy results in improved d-ose distribution when compared with three--dimensional treatm- ent-planning techniques[J]. Int J Radiat Oncol Biol Phys, 2008, 70(1): 296-302.
  • 8Ohashi T, Takeda A, Shigematsu N, et al. Dose distribution anal- ysis of axillary lymph nodes for three-dimensional conformal ra- diotherapy with a field-in-field technique for breast cancer[J]. I- nt J Radiat Oncol Biol Phys, 2009, 73(1): 80-87.
  • 9Mihai A, Rakovitch E, Sixel K, et aL Inverse vs forward breast I- MRT planning[J]. Med Dosim, 2005, 30(3): 149-154.
  • 10Partridge M, Aldridge S, Donovan E, et al. An intercomparison of IMRT delivery techniques: a case study for breast treatment[J]. Phys Med Biol, 2001, 46(7): N175-185.

共引文献34

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部